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pro-inflammatory cytokine and chemokine production by primary renal tubular epi-
thelial cells and monocytes/macrophages. ConClusions: These findings demon-
strate that administration of forskolin is beneficial for controlling the development 
of UPEC mediated acute pyelonephritis in mice. The protective effect of forskolin 
(via cAMP activation) in this experimental acute pyelonephritis can be explained at 
least in part by limiting excessive inflammatory responses through acting on both 
renal parenchymal and inflammatory cells.
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objeCtives: To determine if blocking C5aR could effectively protect mice from UPEC 
induced kidney infection. Methods: A well-established mouse model of ascending 
UTI leading to kidney infection was employed. C5aR antagonist (C5aRa, W54011) 
(250mg/kg) was given before the induction of infection by i.p. injection. Kidney 
infection was assessed in C5aRa or control reagent treated mice at 6, 24, 72h after 
bladder inoculation of UPEC. Bacteria load in kidneys was analysed by the agar plate 
assay. Tissue damage was assessed by histopathology. Leukocytes infiltration was 
analysed by immunochemical staining, tissue MPO activity assay and flow cytom-
etry. Renal synthesis of cytokines/chemokines was analysed by RT-PCR. Results: 
Compared to control reagent treated mice, C5aRa treated mice, either from B6 or 
BALB/c background, exhibited significantly lower rates of kidney infection (B6: 37.5% 
vs 100% [n= 16], BALB/c: 26% vs 87% [n= 15]), reduced kidney tissue damage and gene 
expression of KC, IL-6 and TNF-α in kidney tissues. The reduction of kidney infection 
and tissue damage resulting from C5aR blockade was more profound at 48h and 
72h post infection. C5aR blockade led a small reduction of neutrophil infiltration at 
6h, but had no apparent effect on late time point. ConClusions: C5aR blockade 
effectively protected mice from UPEC-induced kidney infection suggesting that C5aR 
signal is a critical pathogenic factor in UTIs, thus representing a promising target 
for treating or preventing human UTIs.
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objeCtives: The increasing prevalence of patients with end-stage renal disease 
in Malaysia is driving up the costs of dialysis care dramatically. Several studies 
have projected significant cost savings by increasing the proportion of patients 
on peritoneal dialysis (PD). This study investigates the five-year health care 
budget impact of variable distribution of adult patients treated with PD and in-
center hemodialysis (ICHD) on government funding in Malaysia. Methods: An 
Excel®-based budget impact model was constructed to assess dialysis-associ-
ated costs when changing dialysis modalities between PD and ICHD. The model 
incorporates the current modality distribution and accounts for Malaysian govern-
ment dialysis payments and EPO costs. Epidemiological data, including dialysis 
prevalence, incidence, mortality, and transplant rate from Malaysian renal registry 
reports, were used to estimate the dialysis patient population for the next five years. 
The baseline scenario assumed a stable distribution of PD (8%) and ICHD (92%) 
over five years. Alternative scenarios included the prevalence of PD increased by 
2.5%, 5.0%, and 7.5% or decreased 1% yearly over five years. All four scenarios were 
accompanied with commensurate changes in ICHD. Results: Under the current 
best available cost information, an increase in the prevalent PD population from 8% 
in 2014 to 18%, 28%, or 38% in 2018 is predicted to result in five-year cumulative sav-
ings for the Malaysian government of RM13.9 million, RM27.9 million, and RM41.96 
million, respectively. If the prevalent PD population were to decrease from 8% in 
2014 to 4.0% by 2018, the total expenditure for dialysis treatments would increase 
by RM5.6 million over the next five years. ConClusions: Under the best available 
cost information associated with PD and HD paid by the Malaysian government, 
increasing the proportion of patients on PD could result in reduction in dialysis-
associated costs in the future.
PUK8
finanCial iMPliCations to taiwan health systeM fRoM Changing the 
dialysis Modality Mix
Yang W.C.1, Hsu C.C.2, Liu F.X.3
1Taipei Veterans General Hospital, Taipei, Taiwan, 2National Health Research Institutes, Taipei, 
Taiwan, 3Baxter Healthcare Corporation, Deerfield, IL, USA
objeCtives: In 2012, 0.3% of Taiwan end-stage renal disease (ESRD) patients 
accounted for 6.64% of National Health Insurance (NHI) dialysis spending. 
We investigated the five-year financial impact of changing the distribution of 
patients undergoing peritoneal dialysis (PD) and in-center hemodialysis (ICHD) 
in Taiwan. Methods: An Excel®-based budget impact model was constructed to 
assess dialysis-associated costs. The model incorporates Taiwan current modal-
ity distribution and accounts for ESRD outpatient and inpatient total health care 
cost. Epidemiological data of ESRD patients from 2000 to 2011 was acquired from 
Taiwan Renal Data System by Taiwan Society of Nephrology. The transplant rate 
was provided by experts in the field. These data were used to estimate dialysis 
population for the next five years. Dialysis costs were obtained by National Health 
Research Institutes (NHRI) Databases for 2008. The baseline scenario assumed a 
stable distribution of PD (10%) and ICHD (90%) over five years. Four scenarios, includ-
the treatment of BPH is lacking. This systematic review registered with PROSPERO 
(registration number: CRD42014007248) aims to provide the evidence for the AE 
associate with tadalafil use in BPH indication. ConClusions: Tadalafil use in BPH 
has now been increasing over the years. The data from published RCTs will help to 
identify the AE associated with its use.
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objeCtives: Dengue fever is a mosquito borne infectious disease that is mainly 
prevalent in tropical and subtropical zones of the world. One of the potential 
complications of dengue fever is acute kidney injury (AKI). Current study aims to 
assess the incidence and risk factors for AKI among dengue patients.  Methods: 
A retrospective review of medical records of dengue infected patients enrolled 
from May 2005 to December 2013 was conducted at a tertiary care hospital in 
Kelantan. Results: Total 124 patient records (male: 63, female: 61) with mean 
age of 29.57± 15.09 were reviewed retrospectively. Out of 124 patients, 104 (83.9%) 
suffered with classical DF, 19 (15.3%) with dengue hemorrhagic fever (DHF) while 
only 1(0.8%) with Dengue shock syndrome (DSS).The prevalence of AKI among 
Dengue patients was found to be 7.2 % (9 patients). On the basis of Acute Kidney 
Injury Network (AKIN) criteria, 2(22%) had stage 1 AKI while remaining 7 (78%) 
had stage 2 AKI. For the purpose of analysis of risk factors for AKI, patients were 
categorized into group I (with AKI) and group II (without AKI). Mann Whitney “U” 
test was used to compare differences between groups. A higher serum creatinine 
(112.39 vs. 56.87; p:0.001), bilirubin (70.81 vs. 48.73; p:0.038), urea (104.50 vs. 58.08; 
p:0.001), WBC (92.25 vs. 59.90; p:0.013) and Hb (90.91 vs. 60.04; p:0.021) levels were 
observed among AKI dengue patients. Though the duration of hospital stay of 
group I was more than group II, but this difference was statistically insignifi-
cant (I=77.33, II= 61.34; p: 0.192). ConClusions: AKI is a least studied and poorly 
understood complication of dengue fever. Such patients are at verge of developing 
DHS/DSS resulting in complicated clinical course and increased mortality. A cau-
tious diagnosis and timely management should be the first and foremost step for 
management of such patients.
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objeCtives: The study aims to determine the different epidemiological factors 
responsible for the cause of hospital readmissions in chronic hemodialysis (HD) 
patients. Methods: Reviewed data of 170 patients with 124 male and 46 female 
patients receiving maintenance HD twice weekly schedule on a Mon/Thu, Tue/Fri, 
Wed/Sat with prevalent adult’s HD patients on period from 1st Jan to Dec 31, 2010 
or continued until close at death, modality change, deviation from HD schedule not 
during a hospital stay, loss to follow-up. Eligible patients were actively recruited who 
were on chronic HD fulfilling the inclusion criteria. ICD-9-CM diagnosis codes were 
used. Results: A total of 170 patients with End-stage renal disease (ESRD) on chronic 
HD included the study cohort. The mean age was 52.4±11.6 years; 27% were women 
with a mean year of patients on hemodialysis of 3.2±2.6. Hypertension 29.3% and 
hypertension with diabetes 26.4% were the leading cause of ESRD and least cause of 
renal failure was seen with polycystic kidney disease, Glomerulonephritis, Interstitial 
nephritis, and others. Hospital readmission was commonly for cardiovascular complications 
62% to infections 31% and other 7%. IHD, Stroke and Congestive heart failure lead to read-
mission and with infection of AV fistula 66% were more commonly seen compared to 
Catheterization. ConClusions: Hypertension is the leading cause for ESRD and car-
diovascular complications were associated with elevated hospital readmission in addition 
to infection. AV fistula is the other common source of infection leading to readmission.
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objeCtives: To investigate the effect of forskolin, on susceptibility/severity of acute 
pyelonephritis and innate immune responses to pathogen using an established 
experimental model of ascending urinary tract infection and primary cell cultures 
(i.e. renal tubular epithelial cells, monocytes/macrophages). Methods: Forskolin 
is produced by the Indian Coleus plant (Coleus forskohlii), which is commonly used 
to raise levels of cyclic AMP (cAMP) in the study and research of cell physiology. 
Forkolin (250mg/kg) was given before the induction of infection by i.p. injection. 
Kidney infection was assessed in forskolin or control reagent treated mice at 6, 24, 
48h after bladder inoculation of UPEC (J96). Bacteria load in kidneys was analyzed 
by the agar plate assay. Tissue damage was assessed by histopathology. Leukocytes 
infiltration was analysed by immunochemical staining, tissue MPO activity assay 
and flow cytometry. Renal synthesis of cytokines/chemokines was analysed by 
RT-PCR. Results: Administration of forskolin significantly reduced bacteria load 
in kidneys and renal tissue damage at both 6 and 24h time points by 10 folds, this 
was associated with reduced intrarenal production of pro-inflammatory cytokines 
and chemokines (e.g. TNF-α , IL-1β , KC, MCP-1) and attenuated intrarenal infiltra-
tion and accumulation of leukocytes (i.e. CD45+. Gr-1+, F4/80+) as well as intrarenal 
myeloperoxidase (MPO) activity. In vitro, forskolinI inhibited LPS or UPEC mediated 
